AseptoRay

Company Overview

Snapshot

Founded in February 2011 by Amir Trifman and Dror Livne, AseptoRay operates with 1–10 employees. The company has raised $2.5 million across one funding round. In September 2015, AseptoRay was recognized as a winner at the Cleantech Open Israel Competition.

Business overview

AseptoRay specializes in developing an eco-friendly cold pasteurization method utilizing ultraviolet technology. This process operates at ambient temperatures, aiming to preserve nutritional values while effectively eliminating spores and heat-resistant molds. The company's technology is designed to enhance food safety, quality, and shelf life, concurrently reducing energy consumption. AseptoRay operates within the Agriculture & Food Technologies sector, specifically targeting food processing and beverage industries globally with its B2B business model.

Strategic signal

In May 2026, AseptoRay ceased to operate, indicating a significant shift in the company's trajectory. This development signals to investors and innovation teams that the company is no longer active in the market, marking the end of its operations in the cleantech and food technology space.

Company Intelligence Q&A

What is AseptoRay's primary technology?

AseptoRay has developed an eco-friendly cold pasteurization method based on ultraviolet technology, which processes food at ambient temperatures to preserve nutritional value and eliminate pathogens.

When was AseptoRay founded and by whom?

AseptoRay was founded in February 2011 by Amir Trifman and Dror Livne.

What was a notable early achievement for AseptoRay?

In September 2015, AseptoRay was announced as one of the winners at the Cleantech Open Israel Competition.

What is the current operational status of AseptoRay?

AseptoRay ceased to operate in May 2026, making it a non-active company.

What is the total disclosed funding AseptoRay has raised?

AseptoRay has raised a total of $2.5 million across one funding round.